Well, this is exciting! Happy to see a familiar price level and on great momentum. Seems like a vein was hit somewhere that got people looking at the potential here. With this kind of momentum, ZERO toxic dilution, Revenue Growth, and New projects like that prescription filling machine on the horizon, what would stop this from hitting the Analyst Price target? LOL Hopefully we will see them revise this target (higher). Long